ID

13770

Beschrijving

Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01402089

Link

https://clinicaltrials.gov/show/NCT01402089

Trefwoorden

Versies (1)
  1. 06-03-16 06-03-16 -
Geüploaded op

6 maart 2016

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Non Small-cell Lung Cancer NCT01402089

Engels

Eligibility Non Small-cell Lung Cancer NCT01402089

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically or cytologically confirmed renal-cell cancer or gastrointestinal stromal tumor (for sunitinib) or non small-cell lung cancer (for erlotinib)
Beschrijving

renal-cell cancer; gastrointestinal stromal tumor; non small-cell lung cancer; sunitinib; erlotinib

Datatype

boolean

Alias
UMLS CUI [1]
C0007134
UMLS CUI [2]
C0238198
UMLS CUI [3]
C0007131
UMLS CUI [4]
C1176020
UMLS CUI [5]
C1135135
both early or advanced tumor stage
Beschrijving

tumor stage

Datatype

boolean

Alias
UMLS CUI [1]
C1300072
indication for the therapeutic use of either sunitinib or erlotinib
Beschrijving

sunitinib; erlotinib

Datatype

boolean

Alias
UMLS CUI [1]
C1176020
UMLS CUI [2]
C1135135
written informed consent and willing to undergo pk-sampling
Beschrijving

informed consent

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
patients > 18 years of age
Beschrijving

age

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
ecog performance status or ≤2
Beschrijving

ecog

Datatype

boolean

Alias
UMLS CUI [1]
C1520224
adequate laboratory parameters:
Beschrijving

laboratory parameters

Datatype

boolean

Alias
UMLS CUI [1]
C0022885
i. serum creatinine and serum bilirubin ≤ 1.5 x uln ii. serum alt and ast ≤ 2.5 x uln (or ≤ 5 in case of liver metastases) iii. serum calcium ≤ 11,6 mg/dl (2.9 mmol/l)
Beschrijving

serum creatinine; serum bilirubin; alt and ast; serum calcium

Datatype

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2]
C0428441
UMLS CUI [3]
C3831581
UMLS CUI [4]
C0728876
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous treatment with sunitinib or erlotinib
Beschrijving

sunitinib; erlotinib

Datatype

boolean

Alias
UMLS CUI [1]
C1176020
UMLS CUI [2]
C1135135
known hypersensitivity to trial drug or any compounds of the drug
Beschrijving

hypersensitivity study drugs

Datatype

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013227
UMLS CUI [1,3]
C0008972
concurrent radiotherapy
Beschrijving

concurrent therapy radiotherapy

Datatype

boolean

Alias
UMLS CUI [1,1]
C0009429
UMLS CUI [1,2]
C1522449
concurrent systemic anticancer treatment with the exception of bisphosphonates and bevacizumab in patients with non small-cell lung cancer
Beschrijving

concurrent therapy cancer treatment; bisphosphonates; bevacizumab

Datatype

boolean

Alias
UMLS CUI [1,1]
C0009429
UMLS CUI [1,2]
C0920425
UMLS CUI [2]
C0012544
UMLS CUI [3]
C0796392
Terug naar het begin van de pagina

Similar models

Eligibility Non Small-cell Lung Cancer NCT01402089

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
renal-cell cancer; gastrointestinal stromal tumor; non small-cell lung cancer; sunitinib; erlotinib
Item
histologically or cytologically confirmed renal-cell cancer or gastrointestinal stromal tumor (for sunitinib) or non small-cell lung cancer (for erlotinib)
boolean
C0007134 (UMLS CUI [1])
C0238198 (UMLS CUI [2])
C0007131 (UMLS CUI [3])
C1176020 (UMLS CUI [4])
C1135135 (UMLS CUI [5])
tumor stage
Item
both early or advanced tumor stage
boolean
C1300072 (UMLS CUI [1])
sunitinib; erlotinib
Item
indication for the therapeutic use of either sunitinib or erlotinib
boolean
C1176020 (UMLS CUI [1])
C1135135 (UMLS CUI [2])
informed consent
Item
written informed consent and willing to undergo pk-sampling
boolean
C0021430 (UMLS CUI [1])
age
Item
patients > 18 years of age
boolean
C0001779 (UMLS CUI [1])
ecog
Item
ecog performance status or ≤2
boolean
C1520224 (UMLS CUI [1])
laboratory parameters
Item
adequate laboratory parameters:
boolean
C0022885 (UMLS CUI [1])
serum creatinine; serum bilirubin; alt and ast; serum calcium
Item
i. serum creatinine and serum bilirubin ≤ 1.5 x uln ii. serum alt and ast ≤ 2.5 x uln (or ≤ 5 in case of liver metastases) iii. serum calcium ≤ 11,6 mg/dl (2.9 mmol/l)
boolean
C0201976 (UMLS CUI [1])
C0428441 (UMLS CUI [2])
C3831581 (UMLS CUI [3])
C0728876 (UMLS CUI [4])
Item Group
C0680251 (UMLS CUI)
sunitinib; erlotinib
Item
previous treatment with sunitinib or erlotinib
boolean
C1176020 (UMLS CUI [1])
C1135135 (UMLS CUI [2])
hypersensitivity study drugs
Item
known hypersensitivity to trial drug or any compounds of the drug
boolean
C0020517 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0008972 (UMLS CUI [1,3])
concurrent therapy radiotherapy
Item
concurrent radiotherapy
boolean
C0009429 (UMLS CUI [1,1])
C1522449 (UMLS CUI [1,2])
concurrent therapy cancer treatment; bisphosphonates; bevacizumab
Item
concurrent systemic anticancer treatment with the exception of bisphosphonates and bevacizumab in patients with non small-cell lung cancer
boolean
C0009429 (UMLS CUI [1,1])
C0920425 (UMLS CUI [1,2])
C0012544 (UMLS CUI [2])
C0796392 (UMLS CUI [3])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial